THE CHANGES IN CONCENTRATION OF SOME CARDIAC BIOMARKERS FOLLOWING RADIOFREQUENCY ABLATION (RFA) FOR ARRHYTHMIAS

Đình Phong Phan 1,2,, Võ Kiên Lê1, Việt Phong Đặng 1
1 Bach Mai hospital
2 HMU

Main Article Content

Abstract

Objectives: This study aims to evaluate the changes in concentration of some cardiac biomarkers (hs-Troponin T, CK, CK-MB, and CRP-hs) following Radiofrequency ablation (RFA) for arrhythmias. Results: Only hs-TnT concentration increased significantly after EPS procedures; however, the mean concentration was still lower than the upper normal limit (UNL). After RFA, 99% of patients had hs-TnT concentration that rose above the UNL, while only 20.2%, 19.2%, and 17.5% of patients had elevated levels of CK, CK-MB, and CRP-hs, respectively. At 3 and 15 hours after the procedures, only hs-TnT and CK-MB concentrations were significantly higher in the RFA group when compared with the EPS group, while the CK and CRP-hs levels were not statistically different. The hs-TnT level following RFA strongly correlated with procedure duration, number of ablations, and total ablation time. Conclusion: hs-TnT was the most sensitive biomarker for myocardial injury after EPS and RFA procedures. Most patients had higher than normal hs-TnT after RF ablation, and this level correlated strongly with procedure duration, number of ablations, and total ablation time.

Article Details

References

1. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2020;41(5):655-720. doi: 10.1093/ eurheartj/ehz467
2. Bhaskaran A, Chik W, Thomas S, Kovoor P, Thiagalingam A. A review of the safety aspects of radio frequency ablation. IJC Heart Vasc. 2015;8:147-153. doi:10.1016/j.ijcha.2015.04.011
3. del Rey JM, Madrid AH, Valiño JM, et al. Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions. Clin Chem. 1998;44(11):2270-2276.
4. Katritsis D, Hossein-Nia M, Anastasakis A, et al. Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J. 1997;18(6):1007-1013. doi: 10.1093/ oxfordjournals.eurheartj.a015358
5. Hirose H, Kato K, Suzuki O, et al. Diagnostic accuracy of cardiac markers for myocardial damage after radiofrequency catheter ablation. J Interv Card Electrophysiol Int J Arrhythm Pacing. 2006;16(3):169-174. doi:10.1007/s10840-006-9034-4
6. Yoshida K, Yui Y, Kimata A, et al. Troponin elevation after radiofrequency catheter ablation of atrial fibrillation: Relevance to AF substrate, procedural outcomes, and reverse structural remodeling. Heart Rhythm. 2014;11(8):1336-1342. doi:10.1016/j.hrthm.2014.04.015